Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 369

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 369
---
 own or in-license may
fail to result in issued patents with claims that cover product candidates in the United States or in other countries. We may also
inadvertently make statements to regulatory agencies during the regulatory approval process that may be inconsistent with positions that
have been taken during prosecution of our patents, which may result in such patents being narrowed, invalidated or held unenforceable.

The patent applications that we own or in-license may fail
to result in issued patents with claims that cover our product candidates or any future product candidate in the United States or
in other countries. Our pending PCT patent applications are not eligible to become issued patents until, among other things, we file
a national stage patent application within 30 months in the countries in which we seek patent protection. If we do not timely file
any national stage patent applications, we may lose our priority date with respect to our PCT patent applications and any patent protection
on the inventions disclosed in such PCT patent applications. We cannot guarantee any current or future patents will provide us with any
meaningful protection or competitive advantage. There is no assurance that all of the potentially relevant prior art relating to our
patents and patent applications have been found, which can prevent a patent from issuing from a pending patent application or be used
to invalidate an issued patent. The examination process may require us to narrow our claims, which may limit the scope of patent protection
that we may ultimately obtain. Even if patents do successfully issue and even if such patents cover our product candidates or any future
product candidate, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowly
construed, invalidated, or held unenforceable, any of which could limit our ability to prevent competitors and other third parties from
developing and marketing similar product candidates or limit the length of terms of patent protection we may have for our product candidates
and technologies. Other companies may also design around technologies we have patented, licensed or developed. In addition, the issuance
of a patent does not give us the right to practice the patented invention. Third parties may have blocking patents that could prevent
us from marketing product candidates or practicing our own patented technology or impose a substantial royalty burden to do so. Any successful
opposition to these patents or any other patents owned by or licensed to us could deprive us of rights necessary for the successful commercialization
of any product candidates that we may develop. Further, if we